@article{JTD8255,
author = {Omar Abdel-Rahman},
title = {Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer?},
journal = {Journal of Thoracic Disease},
volume = {8},
number = {8},
year = {2016},
keywords = {},
abstract = {Lung cancer is a leading cause of cancer-related mortality particularly in its advanced stages (1). The search for more effective therapies to improve the outcome of advanced non-small cell lung cancer (NSCLC) patients is a real hardship for the cancer research community (2). Profound understanding of NSCLC pathobiology has facilitated largely the development of a more personalized style of therapy (3).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/8255}
}